U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07824479) titled 'Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer' on Sept. 11.
Brief Summary: This study intends to employ FAPI and Grazytracer PET/CT to predict the therapeutic response to preoperative immunotherapy-based combination regimens in patients with advanced gastric cancer. The study is expected to provide an early, non-invasive predictive tool for immunotherapy-based combination therapy in gastric cancer, offer molecular imaging-based evidence for treatment stratification, and facilitate the optimization of precision therapeutic strategies.
Study Start Date: June 17, 2025
Study Type: OBSERVATIONAL
Conditi...